Skip to content

Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols

Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00834548
Enrollment
26
Registered
2009-02-03
Start date
2008-06-30
Completion date
2008-08-31
Last updated
2009-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Intermittent Claudication

Keywords

Magnetic resonance, whole body, angiography, hybrid protocol, MRI

Brief summary

To compare to different approaches in whole-body magnetic resonance angiography of patients suffering peripheral arterial disease. Our hypothesis is that use of a new protocol improves the diagnostic quality of the WB-MRA procedure.

Detailed description

Patients suffering peripheral arterial disease must undergo imaging procedures before endovascular or surgical procedures. WB-MRA is an imaging procedure that can visualise the arterial system. WB-MRA can be performed in different manners. On option is to start the scan in the head region and continue down the body to the feet (standard protocol). Another option is to use a hybrid protocol that first examines the head and lower leg followed by examination of the pelvic and upper leg region. A comparison between the standard and hybrid protocols has not been performed in a 3T high magnetic field system, therefore we will perform such a study.

Interventions

PROCEDUREWhole body magnetic resonance angiography (WB-MRA)

WB-MRA will be performed once in each patient.

Sponsors

Rigshospitalet, Denmark
CollaboratorOTHER
Copenhagen University Hospital at Herlev
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Symptomatic lower extremity ischemia (claudication, ischemic wounds) * Referred to digital subtraction angiography (DSA)

Exclusion criteria

* Renal insufficiency (GFR \< 30 ml/min) * Contra-indications for MRI-examination (claustrophobia, metal-implants, pacemaker) * Dementia * Pregnancy/lactation * Allergy to gadolinium based MRI contrast agents * Acute disease

Design outcomes

Primary

MeasureTime frame
Diagnostic quality of WB-MRA

Secondary

MeasureTime frame
Signal to noise ratio
Contrast to noise ratio

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026